Dr. David DiBardino explains how intratumoral therapy is being studied to deliver treatment directly into tumors and potentially enhance radiation in patients with locally advanced non-small cell lung cancer.
Dr. David DiBardino
Advertisement
Articles by Dr. David DiBardino
An estimated 70% of patients with stage 3 lung cancer do not see their tumors respond to standard treatment. An expert explains why, and what a new approach aims to change.
Advertisement
Latest Updated Articles
How Intratumoral Therapy Is Being Studied in Stage 3 Lung CancerSeptember 27th 2026
Advertisement
Advertisement
Trending on CURE
1
Exercise Gave Me Control. It Didn’t Cure My Cancer
2
Living With Incurable Cancer: The Emotional Toll of Never Knowing What Comes Next
3
A Light-Based Treatment Is Now FDA Approved for a Common Skin Cancer
4
Endoscopic Nipple-Sparing Mastectomy: What Breast Cancer Patients Should Know
5